As of Feb 24
| +0.06 / +0.21%|
The 6 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 33.00, with a high estimate of 38.00 and a low estimate of 27.00. The median estimate represents a +13.17% increase from the last price of 29.16.
The current consensus among 6 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.